NOVAVAX INC (NVAX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NVAX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NVAX | Independent Director; Former Chief Financial Officer | 55 | ["Chief Financial Officer at Lyell Immunopharma, Inc. (2021 to 2025)","Managing Director & Co-Head of Healthcare Investment Banking in the Americas at Bank of America (2015 to 2021)","Managing Director, Co-Head of Healthcare Investment Banking in the Americas at Credit Suisse (2010 to 2015)","Managing Director and Head of Western Region Healthcare Investment Banking at Morgan Stanley (June 1996 to September 2010)","Experience on various public pharmaceutical company boards","M.B.A. from The Tuck School of Business at Dartmouth College","Bachelor of Science in Finance from Miami University","Industry Experience","Executive Leadership","Accounting, Financial or Investment Experience","Public Company Board"] | ["Audit","Nominating & Corporate Governance","Capital Allocation","Nominating and Corporate Governance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
AGE 55 INDEPENDENT DIRECTOR SINCE 2025 COMMITTEES Audit Nominating & Corporate Governance Capital Allocation CAREER HIGHLIGHTS Lyell Immunopharma, Inc. Chief Financial Officer (2021 to 2025) Bank of America Managing Director & Co-Head of Healthcare Investment Banking in the Americas (2015 to 2021) Credit Suisse Managing Director, Co-Head of Healthcare Investment Banking in the Americas (2010 to 2015) Morgan Stanley Managing Director and Head of Western Region Healthcare Investment Banking (June 1996 to September 2010) OTHER CURRENT DIRECTORSHIPS Coherus Oncology (Nasdaq: CHRS) Keros Therapeutics, Inc. (Nasdaq: KROS) EDUCATION M.B.A., The Tuck School of Business at Dartmouth College Bachelor of Science in Finance, Miami University KEY SKILLS AND QUALIFICATIONS Mr. Newton is well-suited to serve on our Board due to his more than 30 years of experience in finance and healthcare investment. Mr. Newton brings experience serving on various public pharmaceutical company boards.